European Journal of Pharmaceutics and Biopharmaceutics

Show Articles
Journal Properties
  • Formerly known as
    Acta Pharmaceutica Technologica
  • Country
    Netherlands
  • Language
    English, French, German
  • Number of Articles
    6,239
  • ISSN
    0939-6411
  • Main Publisher
    Elsevier
  • Publisher
    Elsevier BV
  • Indian UGC
  • DOAJ (latest)
Journal Properties
  • Medicine
    Public aspects of medicine
    Toxicology
    Poisons
    Medicine
    Therapeutics
    Pharmacology
  • website
Description
The European Journal of Pharmaceutics and Biopharmaceutics is a leading journal in the fields of drug delivery, pharmaceutical technology, and biopharmaceutics. This journal publishes high-quality research articles, reviews, and short communications that address various aspects of drug development, formulation, and delivery systems. Focusing on both fundamental and applied research, key areas covered include drug absorption, distribution, metabolism, and excretion (ADME), novel drug carriers, controlled release technologies, and the optimization of drug products for improved efficacy and safety. The journal covers advancements in biopharmaceutics. It bridges the gap between pharmaceutical sciences and clinical applications, making it essential reading for researchers, pharmaceutical scientists, and industry professionals involved in drug development. By providing a platform for innovative research and critical analysis, the European Journal of Pharmaceutics and Biopharmaceutics contributes to the advancement of pharmaceutical sciences and the development of more effective and patient-friendly drug therapies.